Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine vs venlafaxine for taxane-induced neuropathy
IRCT20220115053723N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of duloxetine and venlafaxine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Tehran University of Medical Sciences. Started Feb 2019; status: completed.
02
Drugs
duloxetinevenlafaxine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20220115053723N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220115053723N1.